These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 5509277)

  • 1. [Hemagglutination inhibiting antibodies to measles, rubella, and parotitis. Study of their prevalence in a community of the Mexican plateau].
    Golubjatnikov R; Leppla L; Filloy L
    Salud Publica Mex; 1970; 12(5):603-9. PubMed ID: 5509277
    [No Abstract]   [Full Text] [Related]  

  • 2. [Seroepidemiology of measles, rubella and mumps in the republic of Mexico. II. Methodology and characteristics of a sample in the republic of Mexico].
    Gutiérrez G; César Margáin J; Ludlow A; Blancarte I; Valdéz S
    Salud Publica Mex; 1978; 20(1):13-7. PubMed ID: 752928
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevalence of antibodies and vaccination against measles, mumps and rubella in Polish population].
    Janaszek-Seydlitz W; Bucholc B; Wysokińska T; Górska P; Gniadek G
    Przegl Epidemiol; 2003; 57(2):281-8. PubMed ID: 12910596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroepidemiology of measles, mumps and rubella virus infections in normal children and adults in southern Granada, Spain: response to a vaccination programme.
    Gutiérrez J; Rodríguez M; Huber E; Muñoz A; Piédrola G; Maroto C
    Microbios; 1996; 88(356):143-8. PubMed ID: 9141711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles, mumps, and rubella.
    Stat Bull Metropol Life Insur Co; 1980; 61(3):8-10. PubMed ID: 7256801
    [No Abstract]   [Full Text] [Related]  

  • 6. [Seroprevalence of antibodies against measles, rubella, mumps and varicella among school children in Madrid].
    Gil Miguel A; Astasio Arbiza P; Ortega Molina P; Domínguez Rojas V; González López A
    An Esp Pediatr; 1999 May; 50(5):459-62. PubMed ID: 10394183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Kinetics of infection with toxoplasma gondii, rubella-, mumps- and cytomegalovirus (author's transl)].
    Berger J
    Zentralbl Bakteriol Orig A; 1973 Oct; 224(4):503-22. PubMed ID: 4150118
    [No Abstract]   [Full Text] [Related]  

  • 8. [Vaccination rate for triple measles-rubella-mumps vaccine in Empoli Val d'Elsa area health district U.S.L. 11, Tuscany Region].
    Salvadori P
    Ann Ig; 1998; 10(1):19-24. PubMed ID: 9616974
    [No Abstract]   [Full Text] [Related]  

  • 9. Incidence of mumps and immunity to measles, mumps and rubella among US military recruits, 2000-2004.
    Eick AA; Hu Z; Wang Z; Nevin RL
    Vaccine; 2008 Jan; 26(4):494-501. PubMed ID: 18155326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measles, rubella, and congenital rubella syndrome--United States and Mexico, 1997-1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Nov; 49(46):1048-50, 1059. PubMed ID: 11105768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines.
    Heath TC; Burgess MA; O'Brien ED
    Commun Dis Intell; 1998 Aug; 22(8):159. PubMed ID: 9735551
    [No Abstract]   [Full Text] [Related]  

  • 12. Immediate injection pain in infants aged 18 months during vaccination against measles, mumps and rubella with either Priorix or MMR-II.
    Knutsson N; Jansson UB; Alm B
    Vaccine; 2006 Jul; 24(31-32):5800-5. PubMed ID: 16765490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The determination of susceptibility to measles, rubella, mumps and chickenpox in students of health-related areas].
    Oliveira J; Dias N; Ferreira TM; da Cunha S; Costa D; Côrte-Real R; Meliço-Silvestre A
    Acta Med Port; 1999; 12(4-6):155-60. PubMed ID: 10481316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outbreak of measles and rubella in refugee transit camps.
    Kouadio IK; Koffi AK; Attoh-Toure H; Kamigaki T; Oshitani H
    Epidemiol Infect; 2009 Nov; 137(11):1593-601. PubMed ID: 19379539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Seroepidemiology of rubella, measles and mumps in the Republic of Mexico. IV. Rubella].
    Ruíz-Gómez J; Espinosa-Larios EL
    Salud Publica Mex; 1978; 20(1):29-33. PubMed ID: 752930
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence of antibodies to measles and rubella in Sana'a, Yemen.
    Sallam TA; Al-Jaufy AY; Al-Shaibany KS; Ghauth AB; Best JM
    Vaccine; 2006 Sep; 24(37-39):6304-8. PubMed ID: 16815602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Health and economic benefits of mandatory regular vaccination in Slovakia. IV. Measles, rubella and mumps].
    Hudecková H; Straka S; Avdicová M; Rusnáková S
    Epidemiol Mikrobiol Imunol; 2001 Feb; 50(1):31-5. PubMed ID: 11233671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measles, mumps, and rubella.
    Stat Bull Metropol Life Insur Co; 1977 Nov; 58():2-4. PubMed ID: 595028
    [No Abstract]   [Full Text] [Related]  

  • 19. [The prevalence of measles, rubella, mumps and chickenpox antibodies in a population of health care workers].
    Oliveira J; da Cunha S; Côrte-Real R; Sampaio L; Dais N; Meliço-Silvestre A
    Acta Med Port; 1995 Apr; 8(4):206-16. PubMed ID: 7625214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sero-epidemiology of measles and mumps in Korea: impact of the catch-up campaign on measles immunity.
    Kim SS; Han HW; Go U; Chung HW
    Vaccine; 2004 Dec; 23(3):290-7. PubMed ID: 15530670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.